HALO
HALOZYME THERAPEUTICS INCData as of 2026 Q1 (03-31) · 13F snapshot
Summary
HALOZYME THERAPEUTICS INC (HALO) is held by 6 tracked hedge-fund managers, a combined reported value of ~$190.75M; the largest are Joel Greenblatt, Renaissance Technologies, Ray Dalio. This quarter: 1 new, 2 added, 2 trimmed. 10 members of Congress have disclosed STOCK Act trades. Data as of 2026 Q1, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Mixed
Gurus holding6
Congress trades10
Price$81.48vs quarter-end+26.07%
Sectors0
This quarter's moves
Top holderJoel GreenblattNew1
Added2
Trimmed / sold2
Value $5.75M— of portfolio582,4002016 Q4
Value $3.37M— of portfolio50,0002025 Q4
Value $3.10M— of portfolio48,0002026 Q1
Value $2.77M— of portfolio42,8002026 Q1
Value $282.7K— of portfolio7,4002023 Q3
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Steven CohenPUT | $5.75M | — | — |
| Izzy EnglanderCALL | $3.37M | — | — |
| Ken GriffinCALL | $3.10M | — | — |
| Ken GriffinPUT | $2.77M | — | — |
| Izzy EnglanderPUT | $282.7K | — | — |
Data from public SEC 13F & STOCK Act filings, delayed up to ~45 days, partial holdings only — for research, not investment advice.